Clinical Trials Browser

Phase 2 × Glioma × Palonosetron × Clear all

NCT00900757 2019-08-28

Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide

Phase 2 Completed

57 enrolled 10 charts

Glioma